David Priestley, Regulatory Affairs

David Priestley

David Priestley has extensive regulatory experience from roles in government, industry, trade association and with a specialist regulatory CRO. His particular skills are in supporting early product development and transition from preclinical to clinical phases and due diligence activities, with particular expertise in regulatory CMC requirements and clinical development of products in oncology and immunology, with emphasis on: